SE8605616D0 - Nucvleic acid derivatives - Google Patents

Nucvleic acid derivatives

Info

Publication number
SE8605616D0
SE8605616D0 SE8605616A SE8605616A SE8605616D0 SE 8605616 D0 SE8605616 D0 SE 8605616D0 SE 8605616 A SE8605616 A SE 8605616A SE 8605616 A SE8605616 A SE 8605616A SE 8605616 D0 SE8605616 D0 SE 8605616D0
Authority
SE
Sweden
Prior art keywords
sulphur
substituted
polymers
nucvleic
acid derivatives
Prior art date
Application number
SE8605616A
Other languages
English (en)
Other versions
SE8605616L (sv
SE469594B (sv
Inventor
J Yano
T Ohgi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE8605616D0 publication Critical patent/SE8605616D0/sv
Publication of SE8605616L publication Critical patent/SE8605616L/sv
Publication of SE469594B publication Critical patent/SE469594B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8605616A 1986-01-06 1986-12-30 Nukleinsyraderivat SE469594B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP107686 1986-01-06

Publications (3)

Publication Number Publication Date
SE8605616D0 true SE8605616D0 (sv) 1986-12-30
SE8605616L SE8605616L (sv) 1987-07-07
SE469594B SE469594B (sv) 1993-08-02

Family

ID=11491410

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605616A SE469594B (sv) 1986-01-06 1986-12-30 Nukleinsyraderivat

Country Status (11)

Country Link
JP (1) JPS62252798A (sv)
KR (1) KR940004076B1 (sv)
BE (1) BE906157A (sv)
CA (1) CA1315717C (sv)
CH (1) CH671960A5 (sv)
DE (1) DE3700164A1 (sv)
ES (1) ES2004038A6 (sv)
FR (1) FR2596762B1 (sv)
GB (1) GB2185026B (sv)
NL (1) NL8700016A (sv)
SE (1) SE469594B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100644172B1 (ko) 1998-05-25 2006-11-10 니뽄 신야쿠 가부시키가이샤 핵산 함유 복합체 제제의 제조 방법
WO2003023031A1 (fr) * 2001-09-04 2003-03-20 Nippon Shinyaku Co., Ltd. Methode d'evaluation de l'efficacite d'une therapie aux acides nucleiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906851A (en) * 1960-05-03 1962-09-26 Schwarz Bio Res Inc Thiolation of polymers
DE2041735A1 (de) * 1970-08-22 1972-02-24 Merck Patent Gmbh Thio-pyrimidin-derivate
GB1364987A (en) * 1971-06-19 1974-08-29 Merck Patent Gmbh Biologically active two component complexes
GB2038628A (en) * 1978-11-14 1980-07-30 Searle & Co Physiological compositions comprising poly(4-thiouridylic acid) or copolymers thereof and the use thereof as anti-viral agents or serum cholesterol lowering agents

Also Published As

Publication number Publication date
NL8700016A (nl) 1987-08-03
JPS62252798A (ja) 1987-11-04
GB2185026B (en) 1990-08-08
FR2596762A1 (fr) 1987-10-09
KR940004076B1 (ko) 1994-05-11
BE906157A (fr) 1987-07-01
FR2596762B1 (fr) 1993-10-08
CH671960A5 (sv) 1989-10-13
KR870007198A (ko) 1987-08-17
SE8605616L (sv) 1987-07-07
SE469594B (sv) 1993-08-02
CA1315717C (en) 1993-04-06
ES2004038A6 (es) 1988-12-01
DE3700164A1 (de) 1987-07-09
GB8700183D0 (en) 1987-02-11
GB2185026A (en) 1987-07-08
DE3700164C2 (sv) 1993-02-25

Similar Documents

Publication Publication Date Title
DE69116750T2 (de) 9-Purinyl-Phosphonsäurederivate
CY1109928T1 (el) 8-[3-αμινο-πιπεριδιν-1-υλο]-ξανθινες, παραγωγη αυτων και χρηση τους ως φαρμακων
HN1998000035A (es) Nuevos derivados del acido hexanoico
NO992617L (no) Sulfinsyrederivater, deres fremstilling og anvendelse
ATE114169T1 (de) Morphogenetisches knochenprotein.
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
ES2035668T3 (es) Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
DE3683883D1 (de) Verfahren zur herstellung von organopolysilanen und verwendung der so hergestellten organopolysilane.
DE3667470D1 (de) Griseolinsaeurederivate, ihre herstellung und ihre verwendung.
DE3485419D1 (de) Glyzerinderivate.
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
SE8605616L (sv) Nukleinsyraderivat
BR9908964A (pt) Processo para produção de derivados de purina e intermediários para os mesmos
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
DK0443918T3 (da) Hidtil ukendte derivater af 20,21-dinoreburnamenin, deres fremstilling og anvendelse som lægemidler, samt mellemprodukter og farmaceutiske peæparater med indhold heraf
ES2053478T3 (es) Proceso mejorado para preparar 2,4-quinazolinodiaminas 5,6-substituidas y nuevos intermedios.
FI870873A0 (fi) Isohexid-nukleosid.
ES2097023T3 (es) Derivados del acido succinoilamino-hidroxietilamino-sulfamico utiles como inhibidores de proteasas retrovirales.
ATE298766T1 (de) Veränderung der herstellung von alpha-interferon
IT1205699B (it) Derivati di acidi nucleici,fisiolo gicamente attivi,utili come composti farmaceutici
DK382183D0 (da) I 6-stilling usubstituerede 7-oxo-4-oxa-diazabicyclo(3.2.0)hept-2-en-derivater, fremgangsmader til deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af beta-lactamantibiotika
IT1201252B (it) Procedimento per la decurazione di pelli con vello di pelo ed altro,con coloranti trasferiti da supporto
DE59406501D1 (de) Substituierte iminoacetonitrile mit myokardprotektiver wirkung

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8605616-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8605616-5

Format of ref document f/p: F